SOTIGALIMAB
UNII JEA93WJ5DG

Substance Identification & Data

This profile provides standardized clinical and technical data for Sotigalimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) JEA93WJ5DG.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2305607-45-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

JEA93WJ5DG

CAS Registry Number

2305607-45-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SOTIGALIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C123734

National Cancer Institute reference terminology for clinical and research data.

INN ID

11472

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-152

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sotigalimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SOTIGALIMAB

Common Names & Synonyms

CD40 AGONISTIC MONOCLONAL ANTIBODY APX005M

IMMUNOGLOBULIN G1 (270-GLUTAMIC ACID, C-TERMINAL-LYSINE-CLIPPED), ANTI-(HUMAN CD40 ANTIGEN) (HUMAN-ORYCTOLAGUS CUNICULUS MONOCLONAL APX005M .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-ORYCTOLAGUS CUNICULUS MONOCLONAL APX005M .KAPPA.-CHAIN, DIMER

SOTIGALIMAB [INN]

SOTIGALIMAB [USAN]

SOTIGALIMAB [WHO-DD]